417 related articles for article (PubMed ID: 20533302)
21. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
[TBL] [Abstract][Full Text] [Related]
22. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
Kondo H; Guo J; Bringhurst FR
J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
[TBL] [Abstract][Full Text] [Related]
23. Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone.
Locklin RM; Khosla S; Turner RT; Riggs BL
J Cell Biochem; 2003 May; 89(1):180-90. PubMed ID: 12682918
[TBL] [Abstract][Full Text] [Related]
24. Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts.
Jilka RL; O'Brien CA; Ali AA; Roberson PK; Weinstein RS; Manolagas SC
Bone; 2009 Feb; 44(2):275-86. PubMed ID: 19010455
[TBL] [Abstract][Full Text] [Related]
25. Impaired osteoclast formation in bone marrow cultures of Fgf2 null mice in response to parathyroid hormone.
Okada Y; Montero A; Zhang X; Sobue T; Lorenzo J; Doetschman T; Coffin JD; Hurley MM
J Biol Chem; 2003 Jun; 278(23):21258-66. PubMed ID: 12665515
[TBL] [Abstract][Full Text] [Related]
26. EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone.
Takyar FM; Tonna S; Ho PW; Crimeen-Irwin B; Baker EK; Martin TJ; Sims NA
J Bone Miner Res; 2013 Apr; 28(4):912-25. PubMed ID: 23165727
[TBL] [Abstract][Full Text] [Related]
27. Serum Amyloid A3 Secreted by Preosteoclasts Inhibits Parathyroid Hormone-stimulated cAMP Signaling in Murine Osteoblasts.
Choudhary S; Goetjen A; Estus T; Jacome-Galarza CE; Aguila HL; Lorenzo J; Pilbeam C
J Biol Chem; 2016 Feb; 291(8):3882-94. PubMed ID: 26703472
[TBL] [Abstract][Full Text] [Related]
28. Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss.
Tawfeek H; Bedi B; Li JY; Adams J; Kobayashi T; Weitzmann MN; Kronenberg HM; Pacifici R
PLoS One; 2010 Aug; 5(8):e12290. PubMed ID: 20808842
[TBL] [Abstract][Full Text] [Related]
29. Accentuated osteoclastic response to parathyroid hormone undermines bone mass acquisition in osteonectin-null mice.
Machado do Reis L; Kessler CB; Adams DJ; Lorenzo J; Jorgetti V; Delany AM
Bone; 2008 Aug; 43(2):264-273. PubMed ID: 18499553
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro.
Saleh H; Eeles D; Hodge JM; Nicholson GC; Gu R; Pompolo S; Gillespie MT; Quinn JM
Endocrinology; 2011 May; 152(5):1911-22. PubMed ID: 21363931
[TBL] [Abstract][Full Text] [Related]
31. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway.
Wijenayaka AR; Kogawa M; Lim HP; Bonewald LF; Findlay DM; Atkins GJ
PLoS One; 2011; 6(10):e25900. PubMed ID: 21991382
[TBL] [Abstract][Full Text] [Related]
32. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
[TBL] [Abstract][Full Text] [Related]
33. Mathematical model of paracrine interactions between osteoclasts and osteoblasts predicts anabolic action of parathyroid hormone on bone.
Komarova SV
Endocrinology; 2005 Aug; 146(8):3589-95. PubMed ID: 15860557
[TBL] [Abstract][Full Text] [Related]
34. Cell-to-Cell adhesion via intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 pathway is involved in 1alpha,25(OH)2D3, PTH and IL-1alpha-induced osteoclast differentiation and bone resorption.
Okada Y; Morimoto I; Ura K; Watanabe K; Eto S; Kumegawa M; Raisz L; Pilbeam C; Tanaka Y
Endocr J; 2002 Aug; 49(4):483-95. PubMed ID: 12402981
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects.
Yao W; Cheng Z; Shahnazari M; Dai W; Johnson ML; Lane NE
J Bone Miner Res; 2010 Feb; 25(2):190-9. PubMed ID: 19594295
[TBL] [Abstract][Full Text] [Related]
36. Parathyroid hormone signaling in mature osteoblasts/osteocytes protects mice from age-related bone loss.
Uda Y; Saini V; Petty CA; Alshehri M; Shi C; Spatz JM; Santos R; Newell CM; Huang TY; Kochen A; Kim JW; Constantinou CK; Saito H; Held KD; Hesse E; Pajevic PD
Aging (Albany NY); 2021 Dec; 13(24):25607-25642. PubMed ID: 34968192
[TBL] [Abstract][Full Text] [Related]
37. PTH differentially regulates expression of RANKL and OPG.
Huang JC; Sakata T; Pfleger LL; Bencsik M; Halloran BP; Bikle DD; Nissenson RA
J Bone Miner Res; 2004 Feb; 19(2):235-44. PubMed ID: 14969393
[TBL] [Abstract][Full Text] [Related]
38. Differential temporal effects of sclerostin antibody and parathyroid hormone on cancellous and cortical bone and quantitative differences in effects on the osteoblast lineage in young intact rats.
Ominsky MS; Brown DL; Van G; Cordover D; Pacheco E; Frazier E; Cherepow L; Higgins-Garn M; Aguirre JI; Wronski TJ; Stolina M; Zhou L; Pyrah I; Boyce RW
Bone; 2015 Dec; 81():380-391. PubMed ID: 26261096
[TBL] [Abstract][Full Text] [Related]
39. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
40. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo.
Walker EC; Poulton IJ; McGregor NE; Ho PW; Allan EH; Quach JM; Martin TJ; Sims NA
J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]